Based on scientific data showing that HPV testing provides better protection against cervical
precancer and cancer than cytology, in 2011 the Dutch Health Council advised the Minister …

Background Cytology-based screening has been a cornerstone of cervical cancer
prevention for decades. Following extensive evidence demonstrating higher sensitivity and …

Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

The human papillomavirus is one of the most common sexually transmitted viruses, and an
infection from this virus may become persistent, leading to diseases such as cervical cancer …

Since being introduced in the 1940s, cervical cytology–despite its limitations–has had
unequivocal success in reducing cervical cancer burden in many countries. However, we …

A systematic review of the available evidence on the role of HPV testing in cervical
screening has been published by the Health Technology Assessment Committee of the UK …

OBJECTIVES: To systematically evaluate the long-term effectiveness and cost-effectiveness
of HPV-based primary cervical cancer screening in the German health care context using a …

Cytological cervical screening is rather inefficient because of relatively high proportions of
false negative and false positive smears. To evaluate the efficiency of high‐risk human …

Cervical cancer remains a significant public health concern, both at a global and a
European level. A number of new technologies such as diagnostic tests for human …

Introduction Human papillomavirus (HPV) testing as the primary cervical cancer screening
method is implemented in several countries. We report data from the first round of a large …